29238290|t|Intermittent Fasting Protects against Alzheimer's Disease Possible through Restoring Aquaporin-4 Polarity.
29238290|a|The impairment of amyloid-beta (Abeta) clearance in the brain plays a causative role in Alzheimer's disease (AD). Polarity distribution of aquaporin-4 (AQP4) is important to remove Abeta from brain. AQP4 polarity can be influenced by the ratio of two AQP4 isoforms M1 and M23 (AQP4-M1/M23), however, it is unknown whether the ratio of AQP4-M1/M23 changes in AD. Histone deacetylase 3 has been reported to be significantly increased in AD brain. Moreover, evidence indicated that microRNA-130a (miR-130a) possibly mediates the regulation of histone deacetylase 3 on AQP4-M1/M23 ratio by repressing the transcriptional activity of AQP4-M1 in AD. This study aimed to investigate whether intermittent fasting (IF), increasing the level of an endogenous histone deacetylases inhibitor beta-hydroxybutyrate, restores AQP4 polarity via miR-130a mediated reduction of AQP4-M1/M23 ratio in protection against AD. The results showed that IF ameliorated cognitive dysfunction, prevented brain from Abeta deposition, and restored the AQP4 polarity in a mouse model of AD (APP/PS1 double-transgenic mice). Additionally, IF down-regulated the expression of AQP4-M1 and histone deacetylase 3, reduced AQP4-M1/M23 ratio, and increased miR-130a expression in the cerebral cortex of APP/PS1 mice. In vitro, beta-hydroxybutyrate was found to down-regulate the expression of AQP4-M1 and histone deacetylase 3, reduce AQP4-M1/M23 ratio, and increase AQP4-M23 and miR-130a expression in 2 muM Abeta-treated U251 cells. Interestingly, on the contrary to the result observed in 2 muM Abeta-treated cells, AQP4 expression was obviously decreased in cells exposed to 10 muM Abeta. miR-130a mimic decreased the expression of AQP4-M1 and the ratio of AQP4-M1/M23, as well as silencing histone deacetylase 3 caused the up-regulation of AQP4 and miR-130a, and the reduction of AQP4-M1/M23 ratio in U251 cells. In conclusion, IF exhibits beneficial effects against AD. The mechanism may be associated with recovery of AQP4 polarity, resulting from the reduction of AQP4-M1/M23 ratio. Furthermore, beta-hydroxybutyrate may partly mediate the effect of IF on the reduction of AQP4-M1/M23 ratio in AD, in which miR-130a and histone deacetylase 3 may be implicated.
29238290	38	57	Alzheimer's Disease	Disease	MESH:D000544
29238290	85	96	Aquaporin-4	Gene	11829
29238290	139	144	Abeta	Gene	11820
29238290	195	214	Alzheimer's disease	Disease	MESH:D000544
29238290	216	218	AD	Disease	MESH:D000544
29238290	246	257	aquaporin-4	Gene	361
29238290	259	263	AQP4	Gene	361
29238290	288	293	Abeta	Gene	11820
29238290	306	310	AQP4	Gene	361
29238290	358	362	AQP4	Gene	361
29238290	384	388	AQP4	Gene	361
29238290	442	446	AQP4	Gene	361
29238290	465	467	AD	Disease	MESH:D000544
29238290	469	490	Histone deacetylase 3	Gene	8841
29238290	542	544	AD	Disease	MESH:D000544
29238290	586	599	microRNA-130a	Gene	406919
29238290	601	609	miR-130a	Gene	406919
29238290	647	668	histone deacetylase 3	Gene	8841
29238290	672	676	AQP4	Gene	361
29238290	736	740	AQP4	Gene	361
29238290	747	749	AD	Disease	MESH:D000544
29238290	887	907	beta-hydroxybutyrate	Chemical	MESH:D020155
29238290	918	922	AQP4	Gene	11829
29238290	936	944	miR-130a	Gene	387149
29238290	967	971	AQP4	Gene	11829
29238290	1007	1009	AD	Disease	MESH:D000544
29238290	1050	1071	cognitive dysfunction	Disease	MESH:D003072
29238290	1094	1099	Abeta	Gene	11820
29238290	1129	1133	AQP4	Gene	11829
29238290	1148	1153	mouse	Species	10090
29238290	1163	1165	AD	Disease	MESH:D000544
29238290	1171	1174	PS1	Gene	19164
29238290	1193	1197	mice	Species	10090
29238290	1250	1254	AQP4	Gene	11829
29238290	1262	1283	histone deacetylase 3	Gene	15183
29238290	1293	1297	AQP4	Gene	11829
29238290	1326	1334	miR-130a	Gene	387149
29238290	1376	1379	PS1	Gene	19164
29238290	1380	1384	mice	Species	10090
29238290	1396	1416	beta-hydroxybutyrate	Chemical	MESH:D020155
29238290	1462	1466	AQP4	Gene	361
29238290	1474	1495	histone deacetylase 3	Gene	8841
29238290	1504	1508	AQP4	Gene	361
29238290	1536	1540	AQP4	Gene	361
29238290	1549	1557	miR-130a	Gene	406919
29238290	1578	1583	Abeta	Gene	351
29238290	1592	1596	U251	CellLine	CVCL:0021
29238290	1667	1672	Abeta	Gene	351
29238290	1688	1692	AQP4	Gene	361
29238290	1755	1760	Abeta	Gene	351
29238290	1762	1770	miR-130a	Gene	406919
29238290	1805	1809	AQP4	Gene	361
29238290	1830	1834	AQP4	Gene	361
29238290	1864	1885	histone deacetylase 3	Gene	8841
29238290	1914	1918	AQP4	Gene	11829
29238290	1923	1931	miR-130a	Gene	387149
29238290	1954	1958	AQP4	Gene	11829
29238290	1975	1979	U251	CellLine	CVCL:0021
29238290	2041	2043	AD	Disease	MESH:D000544
29238290	2094	2098	AQP4	Gene	11829
29238290	2141	2145	AQP4	Gene	11829
29238290	2173	2193	beta-hydroxybutyrate	Chemical	MESH:D020155
29238290	2250	2254	AQP4	Gene	11829
29238290	2271	2273	AD	Disease	MESH:D000544
29238290	2284	2292	miR-130a	Gene	387149
29238290	2297	2318	histone deacetylase 3	Gene	15183
29238290	Association	406919	8841
29238290	Positive_Correlation	MESH:D020155	406919
29238290	Association	MESH:D000544	11829
29238290	Association	MESH:D000544	406919
29238290	Association	MESH:D020155	351
29238290	Negative_Correlation	MESH:D020155	8841
29238290	Positive_Correlation	MESH:D000544	8841
29238290	Association	361	406919
29238290	Negative_Correlation	MESH:D020155	361
29238290	Association	MESH:D000544	361
29238290	Association	361	8841
29238290	Association	11820	361
29238290	Association	MESH:D000544	11820
29238290	Association	11829	387149
29238290	Association	387149	8841
29238290	Association	MESH:D000544	387149
29238290	Association	11829	406919
29238290	Positive_Correlation	387149	406919

